Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

4(66.7%)

Phase 1

1(16.7%)

Phase 3

1(16.7%)

6Total

N/A(4)

Phase 1(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT05893654Phase 1Enrolling By Invitation

Melphalan Chemoreduction for Ocular Melanoma

Role: collaborator

NCT04047056Not ApplicableCompleted

Effectiveness of Laboral Kinesiotherapy in Prevention of Upper Limb Musculoskeletal Disorders

Role: collaborator

NCT03352154Not ApplicableUnknown

Long Latency Auditory Evoked Potentials (P300) Outcomes in Patients With Unilateral Cochlear Implants

Role: collaborator

NCT03722069Not ApplicableCompleted

Dietary Sodium Intake in Acute Heart Failure

Role: collaborator

NCT03191032Not ApplicableCompleted

Early Sensory Re-education of the Hand With a Sensor Glove Model

Role: collaborator

NCT01132144Phase 3Terminated

Endometrial Injury for Assisted Reproduction

Role: collaborator

All 6 trials loaded